This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective
Email this article to a friend
Effective use of TNF antagonists
-
Correspondence: David Yocum yocum@u.arizona.edu
Arthritis Res Ther 2004, 6(Suppl 2):S24-S30 doi:10.1186/ar997